secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2024-10-21T23:59:59+00:00
Accession:  0001493152-24-041721
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity prices $2.66M registered direct offering and concurrent private placement of common stock and warrants
--------------------------------------------------------------------------------

- Offering includes 2,048,294 shares at $1.30 per share and warrants to buy up to 2,662,782 shares at $1.50.
- Gross proceeds expected ~$2.66M; closing on or about Oct. 21, 2024; WallachBeth Capital acting as placement agent (8% fee).
- Warrants exercisable upon stockholder approval and expire in five years; officers/directors subject to 60-day lock-up.
- Bylaws amended to set quorum at 34% of outstanding shares entitled to vote, effective Oct. 17, 2024.
- Shares offered under effective S-3 shelf; warrants issued in private placement exempt from registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315224041721/0001493152-24-041721-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315224041721/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041721

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer